These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 2487532)
1. Peripheral hemodynamic effects of ibopamine in patients with congestive heart failure. A placebo-controlled, double-blind study. Longhini C; Ansani L; Musacci GF; Aggio S; Baracca E; Toselli T; Ghirardi P Cardiovasc Drugs Ther; 1989 Apr; 3(2):199-202. PubMed ID: 2487532 [TBL] [Abstract][Full Text] [Related]
2. Effects of ibopamine on peripheral hemodynamics: a strain gauge plethysmographic study in patients with congestive heart failure. Musacci GF; Ansani L; Toselli T; Aggio S; Baracca E; Longhini C Arzneimittelforschung; 1986 Feb; 36(2A):380-2. PubMed ID: 3707654 [TBL] [Abstract][Full Text] [Related]
3. Absence of proarrhythmic effects of ibopamine in patients with congestive heart failure. Caponnetto S; Terrachini V; Canale C; Bruzzone F; Licciardello L; Marchetti GV J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S104-10. PubMed ID: 2483435 [TBL] [Abstract][Full Text] [Related]
4. Effects of acute and chronic ibopamine administration on resting and exercise hemodynamics, plasma catecholamines and functional capacity of patients with chronic congestive heart failure. Dei Cas L; Metra M; Visioli O Am J Cardiol; 1992 Sep; 70(6):629-34. PubMed ID: 1354938 [TBL] [Abstract][Full Text] [Related]
5. The hemodynamic effects of ibopamine, a dopamine congener, in patients with congestive heart failure. Leier CV; Ren JH; Huss P; Unverferth DV Pharmacotherapy; 1986; 6(1):35-40. PubMed ID: 3952005 [TBL] [Abstract][Full Text] [Related]
6. Influence of ibopamine on heart rate and arrhythmic pattern in patients with congestive heart failure. A double-blind multicentre study. G Ital Cardiol; 1989 Jan; 19(1):71-80. PubMed ID: 2663585 [TBL] [Abstract][Full Text] [Related]
7. Ibopamine in the treatment of mild chronic heart failure in elderly patients. A double-blind, placebo-controlled study. Azzolini A; Guffanti E; Ronzitti M; Tantalo L; Colantoni A; Pizzorni C Cardiology; 1990; 77 Suppl 5():89-95. PubMed ID: 2279258 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of ibopamine plus prazosin in congestive heart failure. Naidoo DP; Rocke A; Mitha AS S Afr Med J; 1998 Feb; 88 Suppl 1():C25-31. PubMed ID: 9542492 [TBL] [Abstract][Full Text] [Related]
9. Treatment of mild chronic congestive heart failure with ibopamine, hydrochlorothiazide, ibopamine plus hydrochlorothiazide or placebo. A double-blind comparative study. Kleber FX; Thyroff-Friesinger U Cardiology; 1990; 77 Suppl 5():67-74. PubMed ID: 2279255 [TBL] [Abstract][Full Text] [Related]
10. Ibopamine versus digoxin in the treatment of mild congestive heart failure. A double-blind, randomized, placebo-controlled trial. Kleber FX; Thyroff-Friesinger U Cardiology; 1990; 77 Suppl 5():75-80. PubMed ID: 2279256 [TBL] [Abstract][Full Text] [Related]
11. Ibopamine in chronic congestive heart failure: hemodynamic and neurohumoral effects. López-Sendón J Am J Med; 1991 May; 90(5B):43S-49S. PubMed ID: 1675551 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the acute hemodynamic effects of ibopamine and dopamine in chronic congestive heart failure. Sannia L; Ibba GV; Castellaccio M; Dore L Arzneimittelforschung; 1986 Feb; 36(2A):355-9. PubMed ID: 3707649 [TBL] [Abstract][Full Text] [Related]
13. Effect of ibopamine on peripheral haemodynamics. Longhini C; Musacci GF; Ansani L; Toselli T; Artioli M; Bianco L; Ghirardi P Eur J Clin Pharmacol; 1983; 24(5):585-9. PubMed ID: 6873134 [TBL] [Abstract][Full Text] [Related]
14. Hemodynamic evaluation of ibopamine in patients with refractory congestive heart failure. Humar F; Morgera T; Maras P; Camerini F Arzneimittelforschung; 1986 Feb; 36(2A):360-2. PubMed ID: 3707650 [TBL] [Abstract][Full Text] [Related]
15. Hemodynamic evaluation during exercise test after acute and chronic ibopamine treatment in patients with congestive heart failure. Gavazzi A; Mussini A; Bramucci E Arzneimittelforschung; 1986 Feb; 36(2A):366-70. PubMed ID: 3707652 [TBL] [Abstract][Full Text] [Related]
16. Haemodynamic evaluation of ibopamine in severe congestive heart failure. Reffo GC; Turrin M; Gabellini A; Forattini C Eur J Clin Pharmacol; 1984; 26(1):19-22. PubMed ID: 6714289 [TBL] [Abstract][Full Text] [Related]
17. Double-blind placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: results of the Dutch Ibopamine Multicenter Trial (DIMT). van Veldhuisen DJ; Man in 't Veld AJ; Dunselman PH; Lok DJ; Dohmen HJ; Poortermans JC; Withagen AJ; Pasteuning WH; Brouwer J; Lie KI J Am Coll Cardiol; 1993 Nov; 22(6):1564-73. PubMed ID: 7901256 [TBL] [Abstract][Full Text] [Related]
18. Positive inotropic effects of ibopamine in patients with congestive heart failure. A multicenter investigation. Caponnetto S; Allegro A; Bellotti G; Cataldi A; Salvemini M; Portioli I; Prati PL; Gambelli G; Boccanelli A; Zacharo E Arzneimittelforschung; 1986 Feb; 36(2A):386-90. PubMed ID: 3518725 [TBL] [Abstract][Full Text] [Related]
19. Monitored long-term treatment with ibopamine in patients suffering from severe congestive heart failure. Avanzini Z; Bellogini GC; Brusoni B; Ciampani N; Dei Cas L; Gazzola U; Maggi GC; Mangiavacchi M; Metra M; Pinca L Arzneimittelforschung; 1986 Feb; 36(2A):394-7. PubMed ID: 3707656 [TBL] [Abstract][Full Text] [Related]
20. Comparative effects of ibopamine and captopril in mild congestive heart failure. Focus on the long-term effects of inodilation on ventricular arrhythmias. Cocchieri M; Alunni GF; Del Favero A; Fortunati F; Bardelli G; Capponi EA; Regi L; Boschetti E Cardiology; 1990; 77 Suppl 5():36-42. PubMed ID: 2126222 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]